O. Fernández-Calvo

Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study

Vincenza Conteduca, Daniel Wetterskog, Mansour T. A. Sharabiani et al. · Annals of Oncology · 2017 · 263 citations · Full text

Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

Juan Ruiz‐Bañobre, Aurea Molina-Díaz, O. Fernández-Calvo et al. · ESMO Open · 2021 · 46 citations · Full text

A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide

María Piedad Fernández-Pérez, Enrique Pérez, Teresa Alonso‐Gordoa et al. · The Prostate · 2022 · 11 citations · Full text